Compugroup Medical Se Stock Today

CMPUY Stock  USD 14.80  0.31  2.14%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 9

 
High
 
Low
Low
CompuGroup Medical is trading at 14.80 as of the 30th of November 2024; that is 2.14% up since the beginning of the trading day. The stock's open price was 14.49. CompuGroup Medical has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for CompuGroup Medical SE are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of October 2024 and ending today, the 30th of November 2024. Click here to learn more.
KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. KGaA was founded in 1987 and is headquartered in Koblenz, Germany. Compugroup Medical is traded on OTC Exchange in the United States. The company has 52.23 M outstanding shares. More on CompuGroup Medical SE

Moving against CompuGroup OTC Stock

  0.8GMNFF GobiMinPairCorr
  0.68DOCS DoximityPairCorr
  0.65SOLV Solventum CorpPairCorr
  0.6HQY HealthEquityPairCorr
  0.53BAC Bank of America Aggressive PushPairCorr
  0.52AWCMF Alumina LimitedPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

CompuGroup OTC Stock Highlights

Business ConcentrationHealth Information Services, Healthcare (View all Sectors)
CompuGroup Medical SE [CMPUY] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.66 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CompuGroup Medical's market, we take the total number of its shares issued and multiply it by CompuGroup Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. CompuGroup Medical classifies itself under Healthcare sector and is part of Health Information Services industry. The entity has 52.23 M outstanding shares. CompuGroup Medical SE has accumulated about 120.07 M in cash with 165.27 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.3.
Check CompuGroup Medical Probability Of Bankruptcy

CompuGroup Medical Risk Profiles

CompuGroup Stock Against Markets

Picking the right benchmark for CompuGroup Medical otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in CompuGroup Medical otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for CompuGroup Medical is critical whether you are bullish or bearish towards CompuGroup Medical SE at a given time. Please also check how CompuGroup Medical's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in CompuGroup Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Global Markets Map Now

   

Global Markets Map

Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
All  Next Launch Module

CompuGroup Medical Corporate Management

Elected by the shareholders, the CompuGroup Medical's board of directors comprises two types of representatives: CompuGroup Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CompuGroup. The board's role is to monitor CompuGroup Medical's management team and ensure that shareholders' interests are well served. CompuGroup Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CompuGroup Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Helge WeiVP ConnectivityProfile
Angela TeuferConnectivity DACHProfile
Hannes ReichlMD BoardProfile
Alexander WeimerHead CommunicationsProfile
Michael FranzCo CommunicationProfile
Oliver BruzekChief AffairsProfile
MBA LLMMD CFOProfile

Additional Tools for CompuGroup OTC Stock Analysis

When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.